Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 645-654

Spandidos Publications

Access to resources Recommend Favorite

Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 22-28

Bentham Science Publishers

Access to resources Recommend Favorite

Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer

By Koukourakis George   Baksevanis Constantinos   Zambatis Haralambos   Gritzapis Angelos   Maltezos Efstratios   Simopoulos Costantinos   Koukourakis Michael  

International Journal of Radiation Biology, Vol. 85, Iss. 1, 2009-01 ,pp. : 96-104

Informa Healthcare

Access to resources Recommend Favorite

Metallothionein and Fas (CD95) are Expressed in Squamous Cell Carcinoma of the Tongue

By Sundelin K.   Jadner M.   Norberg-Spaak L.   Davidsson A.   Hellquist H.B.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1860-1864

Elsevier

Access to resources Recommend Favorite

Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines

By Rajashekhar G.   Loganath A.   Roy A.C.   Mongelli J.M.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 101-111

Elsevier

Access to resources Recommend Favorite